Induction (I) and concurrent (C) carboplatin/paclitaxel (C/P) with dose escalated thoracic conformal radiotherapy (TCRT) in stage IIIA/B non-small cell lung cancer (NSCLC): A phase I/II trial

Authors :: Jan Halle
J. Clark
Michael J. Schell
R Fraser
J Rosenmann
S Limentani
W Mitchell
Mark A. Socinski
Source :: Lung Cancer. 29:99
Publication Year :: 2000
Publisher :: Elsevier BV, 2000.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
Cancer Research
medicine.medical_specialty
business.industry
non-small cell lung cancer (NSCLC)
Conformal radiotherapy
medicine.disease
Carboplatin/paclitaxel
Phase i ii
Internal medicine
medicine
Stage IIIa
business

Full Text Access

Tools